O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease. (1st July 2015) - Nykiforuk, Cory L.; Johnstone, Darrell; Reid, Ross; Hrehorak, Bryce; Merluza, John; Cheung, Peter; Kodihalli, Shantha; Dupas, Brian; Leonhardt, Melanie; Hoffman, Harmoni; Han, Xiaobing; Saward, Laura; et al.